Abstract
BackgroundBispecific T-cell engagers (BiTEs) are recombinant bispecific proteins designed to stimulate polyclonal T-cell immunity. In recent years, B7H3, a pan-cancer antigen, has been considered a promising target for future immunotherapy....
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have